HHS Secretary Robert F. Kennedy Jr. continues to lead the department amid routine congressional scrutiny, with recent testimonies before House Ways and Means, Senate Health, and other committees in mid-April 2026 defending the fiscal year 2027 budget, staff reductions of 20,000 positions since 2025, and Trump administration health priorities like HHS cuts and WHO withdrawal. These appearances underscore his entrenched role over a year after narrow 52-48 Senate confirmation in February 2025, despite earlier February staff shakeups and Democratic calls for resignation over vaccine skepticism and measles case rises. Absent verified White House pressure or scandal in the past 30 days, trader consensus at 71.5% "No" reflects low near-term exit risk through December 31, though midterm elections could introduce volatility.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated$16,415 Vol.
$16,415 Vol.
$16,415 Vol.
$16,415 Vol.
An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Market Opened: Mar 19, 2026, 2:02 PM ET
Resolver
0x65070BE91...An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Resolver
0x65070BE91...HHS Secretary Robert F. Kennedy Jr. continues to lead the department amid routine congressional scrutiny, with recent testimonies before House Ways and Means, Senate Health, and other committees in mid-April 2026 defending the fiscal year 2027 budget, staff reductions of 20,000 positions since 2025, and Trump administration health priorities like HHS cuts and WHO withdrawal. These appearances underscore his entrenched role over a year after narrow 52-48 Senate confirmation in February 2025, despite earlier February staff shakeups and Democratic calls for resignation over vaccine skepticism and measles case rises. Absent verified White House pressure or scandal in the past 30 days, trader consensus at 71.5% "No" reflects low near-term exit risk through December 31, though midterm elections could introduce volatility.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated
Beware of external links.
Beware of external links.
Frequently Asked Questions